Sarah B. Noonberg - Net Worth and Insider Trading

Sarah B. Noonberg Net Worth

The estimated net worth of Sarah B. Noonberg is at least $0 dollars as of 2024-06-09. Sarah B. Noonberg is the Director of Protagonist Therapeutics Inc and owns about 0 shares of Protagonist Therapeutics Inc (PTGX) stock worth over $0. Details can be seen in Sarah B. Noonberg's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sarah B. Noonberg has not made any transactions after 2021-02-11 and currently still holds the listed stock(s).

Transaction Summary of Sarah B. Noonberg

To

Sarah B. Noonberg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sarah B. Noonberg owns 4 companies in total, including Protagonist Therapeutics Inc (PTGX) , Neoleukin Therapeutics Inc (NLTX) , and Prothena Corp PLC (PRTA) among others .

Click here to see the complete history of Sarah B. Noonberg’s form 4 insider trades.

Insider Ownership Summary of Sarah B. Noonberg

Ticker Comapny Transaction Date Type of Owner
PTGX Protagonist Therapeutics Inc 2022-05-26 director
NLTX Neoleukin Therapeutics Inc 2019-10-10 director
PRTA Prothena Corp PLC 2017-05-16 Chief Medical Officer
LIMIT LIMIT 2023-05-16 director

Sarah B. Noonberg Latest Holdings Summary

Sarah B. Noonberg currently owns a total of 1 stock. Sarah B. Noonberg owns 0 shares of Protagonist Therapeutics Inc (PTGX) as of February 11, 2021, with a value of $0.

Latest Holdings of Sarah B. Noonberg

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PTGX Protagonist Therapeutics Inc 2021-02-11 0 34.80 0

Holding Weightings of Sarah B. Noonberg


Sarah B. Noonberg Form 4 Trading Tracker

According to the SEC Form 4 filings, Sarah B. Noonberg has made a total of 1 transactions in Protagonist Therapeutics Inc (PTGX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Protagonist Therapeutics Inc is the sale of 8,400 shares on February 11, 2021, which brought Sarah B. Noonberg around $212,520.

Insider Trading History of Sarah B. Noonberg

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sarah B. Noonberg Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sarah B. Noonberg Ownership Network

Ownership Network List of Sarah B. Noonberg

No Data

Ownership Network Relation of Sarah B. Noonberg

Insider Network Chart

Sarah B. Noonberg Owned Company Details

What does Protagonist Therapeutics Inc do?

Who are the key executives at Protagonist Therapeutics Inc?

Sarah B. Noonberg is the director of Protagonist Therapeutics Inc. Other key executives at Protagonist Therapeutics Inc include Chief Financial Officer Asif Ali , director & President and CEO Patel Dinesh V Ph D , and Chief Development Officer Suneel Gupta .

Protagonist Therapeutics Inc (PTGX) Insider Trades Summary

Over the past 18 months, Sarah B. Noonberg made no insider transaction in Protagonist Therapeutics Inc (PTGX). Other recent insider transactions involving Protagonist Therapeutics Inc (PTGX) include a net sale of 130,000 shares made by Patel Dinesh V Ph D , a net sale of 25,421 shares made by Asif Ali , and a net sale of 12,975 shares made by William D. Waddill .

In summary, during the past 3 months, insiders sold 26,234 shares of Protagonist Therapeutics Inc (PTGX) in total and bought 0 shares, with a net sale of 26,234 shares. During the past 18 months, 175,244 shares of Protagonist Therapeutics Inc (PTGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 175,244 shares.

Protagonist Therapeutics Inc (PTGX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Protagonist Therapeutics Inc Insider Transactions

No Available Data

Sarah B. Noonberg Mailing Address

Above is the net worth, insider trading, and ownership report for Sarah B. Noonberg. You might contact Sarah B. Noonberg via mailing address: 331 Oyster Point Boulevard, South San Francisco Ca 94080.

Discussions on Sarah B. Noonberg

No discussions yet.